Genetic alterations in thyroid hyperfunctioning adenomas.
Thirty-seven thyroid autonomously hyperfunctioning adenomas were screened for mutations in the TSH receptor (TSHR), G alpha s (gsp), and ras genes. Polymerase chain reaction-amplified fragments of the TSHR C-terminal part (exon 10), the G alpha s (exons 8 and 9), and the three ras genes were obtained from the genomic DNA extracted from 37 tumors and their adjacent normal tissues and were studied by direct nucleotide sequencing and hybridization with synthetic probes. A point mutation in the third intracellular loop (codon 623) of the TSHR was found in 3 of 37 adenomas studied. This mutation codes for a change (Ala to Ser) in the TSHR structure and is somatic and heterozygotic. Constitutive activation of the TSHR was demonstrated by an increase in basal cAMP levels after transfection of Chinese hamster ovary cells with a mutated Ser623-TSHR complementary DNA. Nine gsp[00ae]MDRV[00af]- and one ras-activating mutations were also detected. No simultaneous alteration of the studied genes was present. Thus, in hyperfunctioning thyroid adenomas, our data suggest that a mutational activation of the TSHR and gsp genes may play a tumorigenic role through constitutive activation of the cAMP pathway.
Russo
D
D
Dipartimento di Medicina Sperimentale e Clinica, Facoltà di Farmacia, Università di Reggio Calabria, Catanzaro, Italy.
Arturi
F
F
Wicker
R
R
Chazenbalk
G D
GD
Schlumberger
M
M
DuVillard
J A
JA
Caillou
B
B
Monier
R
R
Rapoport
B
B
Filetti
S
S
D000236:Adenoma / Q000235:genetics* / Q000503:physiopathology*; D000818:Animals; D001483:Base Sequence; D016466:CHO Cells; D006224:Cricetinae; D011905:Genes, ras; D006801:Humans; D015335:Molecular Probes / Q000235:genetics; D008969:Molecular Sequence Data; D009154:Mutation; D011989:Receptors, Thyrotropin / Q000235:genetics / Q000378:metabolism; D013961:Thyroid Gland / Q000503:physiopathology*; D013964:Thyroid Neoplasms / Q000235:genetics* / Q000503:physiopathology*
D015335:Molecular Probes; D011989:Receptors, Thyrotropin